These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
348 related articles for article (PubMed ID: 30607886)
1. Phage antibody library screening for the selection of novel high-affinity human single-chain variable fragment against gastrin receptor: an in silico and in vitro study. Jalilzadeh-Razin S; Mantegi M; Tohidkia MR; Pazhang Y; Pourseif MM; Barar J; Omidi Y Daru; 2019 Jun; 27(1):21-34. PubMed ID: 30607886 [TBL] [Abstract][Full Text] [Related]
2. Selection of potential therapeutic human single-chain Fv antibodies against cholecystokinin-B/gastrin receptor by phage display technology. Tohidkia MR; Asadi F; Barar J; Omidi Y BioDrugs; 2013 Feb; 27(1):55-67. PubMed ID: 23344946 [TBL] [Abstract][Full Text] [Related]
3. Targeting cytokines: production and characterization of anti-TNF-α scFvs by phage display technology. Abdolalizadeh J; Nouri M; Zolbanin JM; Barzegari A; Baradaran B; Barar J; Coukos G; Omidi Y Curr Pharm Des; 2013; 19(15):2839-47. PubMed ID: 23432628 [TBL] [Abstract][Full Text] [Related]
4. Isolation and Characterization of the Vascular Endothelial Growth Factor Receptor Targeting ScFv Antibody Fragments Derived from Phage Display Technology. Kazemzadeh H; Bagheri M; Sepehri M; Ebrahimi E; Wang H; Haider S; Kheirabadi M; Tohidkia MR ACS Omega; 2024 May; 9(20):21964-21973. PubMed ID: 38799304 [TBL] [Abstract][Full Text] [Related]
5. Tailoring subtractive cell biopanning to identify diffuse gastric adenocarcinoma-associated antigens via human scFv antibodies. Mehdipour T; Tohidkia MR; Ata Saei A; Kazemi A; Khajeh S; Rahim Rahimi AA; Nikfarjam S; Farhadi M; Halimi M; Soleimani R; Zubarev RA; Nouri M Immunology; 2020 Jan; 159(1):96-108. PubMed ID: 31596953 [TBL] [Abstract][Full Text] [Related]
6. Generation and molecular docking analysis of specific single-chain variable fragments selected by phage display against the recombinant nucleocapsid protein of fig mosaic virus. Shahmirzaie M; Safarnejad MR; Rakhshandehroo F; Safarpour H; Shirazi FH; Zamanizadeh HR; Elbeaino T J Virol Methods; 2020 Feb; 276():113796. PubMed ID: 31812630 [TBL] [Abstract][Full Text] [Related]
7. Phage display-derived antibody fragments against conserved regions of VacA toxin of Helicobacter pylori. Fahimi F; Sarhaddi S; Fouladi M; Samadi N; Sadeghi J; Golchin A; Tohidkia MR; Barar J; Omidi Y Appl Microbiol Biotechnol; 2018 Aug; 102(16):6899-6913. PubMed ID: 29862446 [TBL] [Abstract][Full Text] [Related]
8. A comparison of three strategies for biopanning of phage-scFv library against diphtheria toxin. Lakzaei M; Rasaee MJ; Fazaeli AA; Aminian M J Cell Physiol; 2019 Jun; 234(6):9486-9494. PubMed ID: 30417355 [TBL] [Abstract][Full Text] [Related]
9. [Inhibitory effect of novel internalized fully human phage antibody fragments on proliferation of lung adenocarcinoma cell line overexpressing peroxiredoxin I]. Luo Y; Pang H; Li SJ; Cao H; Li SL; Fan CB Ai Zheng; 2009 Oct; 28(10):1061-6. PubMed ID: 19799814 [TBL] [Abstract][Full Text] [Related]
10. Invert biopanning: A novel method for efficient and rapid isolation of scFvs by phage display technology. Rahbarnia L; Farajnia S; Babaei H; Majidi J; Veisi K; Tanomand A; Akbari B Biologicals; 2016 Nov; 44(6):567-573. PubMed ID: 27520285 [TBL] [Abstract][Full Text] [Related]
11. Preparation of single chain variable fragment of MG(7) mAb by phage display technology. Yu ZC; Ding J; Nie YZ; Fan DM; Zhang XY World J Gastroenterol; 2001 Aug; 7(4):510-4. PubMed ID: 11819819 [TBL] [Abstract][Full Text] [Related]
12. Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes. Zarei N; Fazeli M; Mohammadi M; Nejatollahi F Breast Cancer Res Treat; 2018 Jun; 169(3):427-436. PubMed ID: 29411237 [TBL] [Abstract][Full Text] [Related]
13. Isolation and Characterization of Cross-Neutralizing Human Anti-V3 Single-Chain Variable Fragments (scFvs) Against HIV-1 from an Antigen Preselected Phage Library. Kumar R; Kumari R; Khan L; Sankhyan A; Parray HA; Tiwari A; Wig N; Sinha S; Luthra K Appl Biochem Biotechnol; 2019 Mar; 187(3):1011-1027. PubMed ID: 30151637 [TBL] [Abstract][Full Text] [Related]
14. Development and characterization of phage display-derived anti-toxin antibodies neutralizing TcdA and TcdB of Raeisi H; Azimirad M; Asadzadeh Aghdaei H; Zarnani AH; Abdolalizadeh J; Yadegar A; Zali MR Microbiol Spectr; 2023 Sep; 11(5):e0531022. PubMed ID: 37668373 [TBL] [Abstract][Full Text] [Related]
15. Isolation of a Novel Anti-KDR3 Single-chain Variable Fragment Antibody from a Phage Display Library. Kordi S; Rahmati-Yamchi M; Asghari Vostakolaei M; Etemadie A; Barzegari A; Abdolalizadeh J Iran J Allergy Asthma Immunol; 2019 Jun; 18(3):289-299. PubMed ID: 31522436 [TBL] [Abstract][Full Text] [Related]
16. One-step expression and purification of single-chain variable antibody fragment using an improved hexahistidine tag phagemid vector. Zhao Q; Chan YW; Lee SS; Cheung WT Protein Expr Purif; 2009 Dec; 68(2):190-5. PubMed ID: 19683057 [TBL] [Abstract][Full Text] [Related]
17. Development of phage-based single chain Fv antibody reagents for detection of Yersinia pestis. Lillo AM; Ayriss JE; Shou Y; Graves SW; Bradbury AR; Pavlik P PLoS One; 2011; 6(12):e27756. PubMed ID: 22174746 [TBL] [Abstract][Full Text] [Related]
18. Screening and evaluation of human single-chain fragment variable antibody against hepatitis B virus surface antigen. Zhang JL; Gou JJ; Zhang ZY; Jing YX; Zhang L; Guo R; Yan P; Cheng NL; Niu B; Xie J Hepatobiliary Pancreat Dis Int; 2006 May; 5(2):237-41. PubMed ID: 16698583 [TBL] [Abstract][Full Text] [Related]
19. Construction and molecular characterization of mouse single-chain variable fragment antibodies against Burkholderia mallei and Burkholderia pseudomallei. Kim HS; Tsai S; Zou N; Lo SC; Wear DJ; Izadjoo MJ J Immunol Methods; 2011 Feb; 365(1-2):101-9. PubMed ID: 21172353 [TBL] [Abstract][Full Text] [Related]
20. Generation and characterization of single-chain antibody fragments specific against transmembrane envelope glycoprotein gp46 of maedi-visna virus. Blazek D; Celer V; Navrátilová I; Skládal P J Virol Methods; 2004 Jan; 115(1):83-92. PubMed ID: 14656464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]